Email Michael Daniels

NASDAQ:FULC Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulcrum Therapeutics, Inc.

Certain directors of Fulcrum Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy